Basit öğe kaydını göster

Cancer stem cells in oncology

dc.contributor.authorTopcul, MEHMET RIFKI
dc.contributor.authorCetin, I.
dc.date.accessioned2021-03-05T10:16:09Z
dc.date.available2021-03-05T10:16:09Z
dc.date.issued2012
dc.identifier.citationCetin I., Topcul M. R. , "Cancer stem cells in oncology", JOURNAL OF BUON, cilt.17, ss.644-648, 2012
dc.identifier.issn1107-0625
dc.identifier.othervv_1032021
dc.identifier.otherav_a22f5090-6593-4c6a-9b30-a5fb03fe75bd
dc.identifier.urihttp://hdl.handle.net/20.500.12627/108658
dc.description.abstractCancer stem cells (CSCs) possess several characteristics including self-renewal, pluripotency and tumorigenicity and constitute a rare population in a tumor mass. Because conventional cancer therapies can not kill CSCs, these cells are responsible for tumor relapse and metastasis. Currently, with advances in the identification of CSCs, the importance of these cells is increasing in the field of cancer diagnosis and prognosis. In addition, clarifying the mechanisms responsible for the maintenance of CSCs properties led to the development of CSC-targeted therapies.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleCancer stem cells in oncology
dc.typeMakale
dc.relation.journalJOURNAL OF BUON
dc.contributor.departmentİstanbul Üniversitesi , Fen Fakültesi , Biyoloji Bölümü
dc.identifier.volume17
dc.identifier.issue4
dc.identifier.startpage644
dc.identifier.endpage648
dc.contributor.firstauthorID59616


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster